Ignite Creation Date:
2025-12-24 @ 11:42 PM
Ignite Modification Date:
2026-01-17 @ 8:58 AM
Study NCT ID:
NCT02864251
Status:
COMPLETED
Last Update Posted:
2023-09-28
First Post:
2016-08-09
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) Participants With Epidermal Growth Factor Receptor (EGFR) Mutation Who Failed 1L or 2L EGFR Tyrosine Kinase Inhibitor (TKI) Therapy
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-03-17
Start Date Type:
ACTUAL
Primary Completion Date:
2022-01-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-10-17
Completion Date Type:
ACTUAL
First Submit Date:
2016-08-09
First Submit QC Date:
None
Study First Post Date:
2016-08-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2023-01-10
Results First Submit QC Date:
None
Results First Post Date:
2023-02-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-09-06
Last Update Post Date:
2023-09-28
Last Update Post Date Type:
ACTUAL